Creso Pharma has moved into the lucrative livestock market with the launch of Anibidiol Swine, a hemp flour and oat bran-based complementary feed for pigs reared indoors and outdoors.
Anibidiol Swine was developed to address tail biting, a common problem in stressed pig herds that can decrease the value of the animals at slaughter.
Creso will begin marketing the product to farmers and breeders through its established partners and distributors in the animal health space, initially in Europe and Latin America. First sales are expected with vets, livestock feed shops and online during H2 CY21.
The swine feed market is projected to grow to US$148 billion by 2027 with a population of more than 150 million pigs in Europe and 67 million in Latin America.
Creso commercial and development director Dr Gian Trepp said: “Anibidiol Swine was developed to address the large need expressed by farmers for an effective, natural and plant-based complementary feed to support the reduction of stress and swine tail biting.
“The launch will provide access into another lucrative vertical for the company and contribute to [its] growing revenue streams.”